Medical Weight Loss for Stamford, Connecticut Residents
Stamford, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Stamford through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Stamford Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Stamford, Connecticut residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Stamford is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Stamford patients at home.
In Stamford, Connecticut, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Downtown, Shippan, and the greater Fairfield County area. Every prescription for Stamford is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
For Stamford residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Stamford is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month · just $7.70/day for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Stamford
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Stamford
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Stamford address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Stamford
How do I get treatment from Stamford?
As a Stamford, Connecticut patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Stamford?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Stamford in cold-pack packaging, no lines and no drive.
How much does it cost for Stamford patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Stamford do you serve?
We serve patients from across Stamford by telehealth, including Downtown, Shippan, and the greater Fairfield County area.
Is bilingual (Spanish) telehealth care available for Stamford patients?
Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Stamford patients.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Stamford, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.